The Blood Glucose Monitoring System Market comprises medical devices used to measure and track blood sugar levels in individuals with diabetes, playing a crucial role in effective disease management and prevention of complications. The market includes Self-Monitoring Blood Glucose (SMBG) systems—such as glucose meters, test strips, and lancets—and Continuous Glucose Monitoring (CGM) systems, which offer real-time glucose data through wearable sensors and transmitters. The growing global prevalence of diabetes, driven by sedentary lifestyles, obesity, and aging populations, remains a primary factor fueling market growth.
According to Fortune Business Insights, the blood glucose monitoring system market share was valued at USD 17.20 billion in 2024 and is projected to grow from USD 18.03 billion in 2025 to USD 27.73 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period. North America dominated the market, accounting for a 44.01% share in 2024.
The Blood Glucose Monitoring System Market report provides a comprehensive assessment of current trends, industry dynamics, market value, and future opportunities. It includes detailed analysis across product types, applications, patient care settings, and regions. The study also highlights technological innovations, clinical adoption rates, and regulatory updates shaping the industry’s future landscape.
Leading players operating in the global market include:
These companies are focusing on innovation, product approvals, and strategic collaborations to strengthen their global presence. Continuous glucose monitoring (CGM) technologies, smart sensors, and user-friendly devices are at the core of their development strategies.